Modafinil for excessive daytime sleepiness in myotonic dystrophy

Neurology

Volumn 56, Issue 6, 2001, Pages 794-796

  Damian, Maxwell S ^a   Gerlach, A ^a   Schmidt, F ^a   Lehmann, E ^a   Reichmann, H ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MODAFINIL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HUMAN; MALE; MEASUREMENT; MYOTONIC DYSTROPHY; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; SIDE EFFECT; SLEEP; SLEEP APNEA SYNDROME; SLEEP PATTERN; SOMNOLENCE;

EID: 0035957279     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.56.6.794     Document Type: Article

References (10)

1. Apathy and hypersomnia are common features of myotonic dystrophy
2. Disruption of sleep-wake rhythmicity and daytime sleepiness in myotonic dystrophy
3. Selegiline in the treatment of hypersomnolence in myotonic dystrophy: A pilot study
4. Baclofen trial in six myotonic dystrophy patients
5. Daytime sleep in myotonic dystrophy is not caused by sleep apnoea
6. Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy
7. Guidelines for the multiple sleep latency test (MSLT): A standard measure of sleepiness
8. A new method for measuring daytime sleepiness: The epworth sleepiness scale
9. Sleep and neuromuscular disease: Bilevel positive airway pressure by nasal mask as a treatment for sleep disordered breathing in patients with neuromuscular disease
10. Modafinil in obstructive sleep apnea-hypopnea syndrome: A pilot study in 6 patients